# Retroprospective Real Life Observatory of Eribulin

> **NCT02393287** · — · COMPLETED · sponsor: **Institut Cancerologie de l'Ouest** · enrollment: 753 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **OTHER:** Eribulin (ReProLine)

## Key facts

- **NCT ID:** NCT02393287
- **Lead sponsor:** Institut Cancerologie de l'Ouest
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2016-09
- **Final completion:** 2017-01
- **Target enrollment:** 753 (ACTUAL)
- **Last updated:** 2019-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02393287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02393287, "Retroprospective Real Life Observatory of Eribulin". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02393287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*